MiRNA-3662 reverses the gemcitabine resistance in pancreatic cancer through regulating the tumor metabolism

Liu, A; Zhou, YG; Zhao, T; Tang, X; Zhou, BB; Xu, J

Zhou, BB (corresponding author), Hunan Inst Sci & Technol, Dept Chem & Chem Engn, Yueyang 414006, Peoples R China.; Xu, J (corresponding author), First Peoples Hosp Yueyang, Dept Gastrointestinal Surg, Yueyang 414000, Peoples R China.; Tang, X (corresponding author), Second Peoples Hosp Yueyang, Dept Intens Care, Yueyang 414006, Peoples R China.

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2021; 88 (2): 343

Abstract

Objectives Gemcitabine (Gem) is one of the most commonly used chemotherapeutic drugs in treating patients with pancreatic ductal adenocarcinoma (PDAC)......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索